Roche Holding AG (RO.SW)

Swiss · Healthcare · Drug Manufacturers - General
402.60 CHF-0.59%As of 2026-11-22 · CHF
Last session low 401.80 CHFLast session high 407.40 CHF
52-week low 301.20 CHF52-week high 417.80 CHF
Market cap (USD)
$382.08B
Sector
Healthcare
P/E (TTM)
26.3x
Dividend yield
2.43%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)52.0In the neutral range (30 to 70)
MACD (12, 26, 9)6.00Below its signal line (7.74); histogram -1.74
Bollinger %B (20, 2)27%Inside the bands (396.99 to 417.61)
SMA 20407.30Price is 1.2% below
SMA 50386.99Price is 4.0% above
SMA 200354.10Price is 13.7% above
ATR (20)1.72% of priceAverage true range per day
52-week position87%In the upper part of the 301.20 to 417.80 range

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Latest fiscal yearEnded 2025-12-31: revenue of 63.36B CHF and an operating margin of 29.2%.

Also listed as ROP.SW (Swiss)

More in Drug Manufacturers - General